Sujini Ponnusamy Driving the Future of Precision Medicine Through AI and Genomics

Recognizing the growing role of genomics in cancer care, she later worked on integrating molecular diagnostics and pharmacogenomics into oncology decision-making. Her contributions include the development of CANLYTx, a precision oncology platform designed to support clinicians with personalized treatment insights based on genomic data.

Ponnusamy has also been a strong advocate for using AI as a clinical support tool, helping healthcare professionals interpret complex genomic and medical data more efficiently. Her work focuses on building AI-enabled healthcare systems that combine genomic, clinical, and diagnostic information to support informed medical decisions.

Beyond research and innovation, she has contributed to broader discussions on the ethical and responsible adoption of AI in healthcare.

As precision medicine continues to gain global momentum, Ponnusamy’s work reflects a growing movement toward healthcare that is more predictive, preventive, and personalized—leveraging technology to improve patient outcomes and transform the future of care.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.